New search engine for single cell atlases
New software tool allows researchers to rapidly search datasets from single-cell sequencing
A new software tool allows researchers to quickly query datasets generated from single-cell sequencing. Users can identify which cell types any combination of genes are active in. Published in Nature Methods on 1st March, the open-access ‘scfind’ software enables swift analysis of multiple datasets containing millions of cells by a wide range of users, on a standard computer.
Processing times for such datasets are just a few seconds, saving time and computing costs. The tool, developed by researchers at the Wellcome Sanger Institute, can be used much like a search engine, as users can input free text as well as gene names.
Techniques to sequence the genetic material from an individual cell have advanced rapidly over the last 10 years. Single-cell RNA sequencing (scRNAseq), used to assess which genes are active in individual cells, can be used on millions of cells at once and generates vast amounts of data (2.2 GB for the Human Kidney Atlas). Projects including the Human Cell Atlas and the Malaria Cell Atlas are using such techniques to uncover and characterise all of the cell types present in an organism or population. Data must be easy to access and query, by a wide range of researchers, to get the most value from them.
To allow for fast and efficient access, a new software tool called scfind uses a two-step strategy to compress data ~100-fold. Efficient decompression makes it possible to quickly query the data. Developed by researchers at the Wellcome Sanger Institute, scfind can perform large scale analysis of datasets involving millions of cells on a standard computer without special hardware. Queries that used to take days to return a result, now take seconds.
The new tool can also be used for analyses of multi-omics data, for example by combining single-cell ATAC-seq data, which measures epigenetic activity, with scRNAseq data.
“The advances of multiomics methods have opened up an unprecedented opportunity to appreciate the landscape and dynamics of gene regulatory networks. Scfind will help us identify the genomic regions that regulate gene activity – even if those regions are distant from their targets.”
Dr Jimmy Lee, Postdoctoral Fellow at the Wellcome Sanger Institute, and lead author of the research
Scfind can also be used to identify new genetic markers that are associated with, or define, a cell type. The researchers show that scfind is a more accurate and precise method to do this, compared with manually curated databases or other computational methods available.
To make scfind more user friendly, it incorporates techniques from natural language processing to allow for arbitrary queries.
“Analysis of single-cell datasets usually requires basic programming skills and expertise in genetics and genomics. To ensure that large single-cell datasets can be accessed by a wide range of users, we developed a tool that can function like a search engine – allowing users to input any query and find relevant cell types.”
Dr Martin Hemberg, former Group Leader at the Wellcome Sanger Institute, now at Harvard Medical School and Brigham and Women’s Hospital
“New, faster analysis methods are crucial for finding promising insights in single-cell data, including in the Human Cell Atlas.User-friendly tools like scfind are accelerating the pace of science and the ability of researchers to build off of each other’s work, and the Chan Zuckerberg Initiative is proud to support the team that developed this technology.” Dr Jonah Cool, Chan Zuckerberg Initiative Science Program Officer
Jimmy Lee et al. (2021) Fast searches of large collections of single cell data using scfind. Nature Methods. DOI: 10.1038/s41592-021-01076-9
This research was supported by the Chan Zuckerberg Initiative and Wellcome.
The Chan Zuckerberg Initiative was founded in 2015 to help solve some of society’s toughest challenges — from eradicating disease and improving education, to addressing the needs of our local communities. Our mission is to build a more inclusive, just, and healthy future for everyone. For more information, please visit www.chanzuckerberg.com.
The Wellcome Sanger Institute is a world leading genomics research centre. We undertake large-scale research that forms the foundations of knowledge in biology and medicine. We are open and collaborative; our data, results, tools and technologies are shared across the globe to advance science. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth. Find out more at www.sanger.ac.uk or follow us on Twitter, Facebook, LinkedIn and on our Blog.
Wellcome exists to improve health by helping great ideas to thrive. We support researchers, we take on big health challenges, we campaign for better science, and we help everyone get involved with science and health research. We are a politically and financially independent foundation. https://wellcome.org/
Related blog posts
14 May 2018
A trusty guide for exploring the complexity of cells
Single cell RNA sequencing data can be used to identify cell types. Martin Hemberg and Vladimir Kiselev explain how their new ...
6 Apr 2018
New computational method reveals where genes are expressed
06.04.18 Valentine Svensson explains how the new computational method SpacialDE interprets single-cell data to identify which genes are switched ...
28 Apr 2014
Single cell genomics: thinking small
28.04.14 Advances in single-cell genomics are starting to reveal just how much diversity can occur within a single organism, ...
24 Jun 2021
Water vole genome will help boost conservation of one of UK's most endangered mammals
The water vole genome is published as part of the Darwin Tree of Life Project to assemble the genomes of 70, ...
23 Jun 2021
Cellular signatures of kidney tumours discovered
This method of identification holds promise as a tool for diagnosing patients with rare cancers